Showing results (131-140 of 296) with videos related to
Sort By:
Pageof 30
Hepatology (Baltimore, Md.)|August 3, 2013
Discovery of novel Src homology region 2 domain-containing phosphatase 1 agonists from sorafenib for the treatment of hepatocellular carcinomaWei-Tien Tai, Chung-Wai Shiau, Pei-Jer Chen, et al.Molecular Cancer Therapeutics|December 20, 2011
Dovitinib induces apoptosis and overcomes sorafenib resistance in hepatocellular carcinoma through SHP-1-mediated inhibition of STAT3Wei-Tien Tai, Ann-Lii Cheng, Chung-Wai Shiau, et al.European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|January 3, 2018
Improving oral bioavailability of resveratrol by a UDP-glucuronosyltransferase inhibitory excipient-based self-microemulsionFei-Fei Yang, Jing Zhou, Xiao Hu, et al.Journal of the American Chemical Society|May 29, 2023
Integration of Metal Catalysis and Organocatalysis in a Metal Nanocluster with Anchored ProlineJia-Qi Wang, Rui-Lin He, Wen-Di Liu, et al.Inorganic Chemistry|February 28, 2019
Tetradecanuclear and Octadecanuclear Gold(I) Sulfido Clusters: Synthesis, Structures, and Luminescent Selective Tracking of Lysosomes in Living CellsChun-Yu Liu, Xue-Rui Wei, Yuan Chen, et al.Bioorganic & Medicinal Chemistry|September 18, 2012
Development of erlotinib derivatives as CIP2A-ablating agents independent of EGFR activityKuen-Feng Chen, Kuan-Chuan Pao, Jung-Chen Su, et al.Plos One|November 13, 2012
25(OH)D(3) affects the maturation and function of mouse bone marrow-derived dendritic cells stimulated by Mycobacterium bovis BCGHui-feng Yang, Ze-hua Zhang, Liang-bi Xiang, et al.Colloids and Surfaces. B, Biointerfaces|May 7, 2020
Enhancing in vivo oral bioavailability of cajaninstilbene acid using UDP-glucuronosyl transferase inhibitory excipient containing self-microemulsionFei-Fei Yang, Ci-Yu Ji, Zhao-Qing Cong, et al.British Journal of Pharmacology|September 18, 2012
Sorafenib and its derivative SC-49 sensitize hepatocellular carcinoma cells to CS-1008, a humanized anti-TNFRSF10B (DR5) antibodyKuen-Feng Chen, Hui-Ling Chen, Chung-Wai Shiau, et al.European Journal of Medicinal Chemistry|September 18, 2012
Synthesis and biological activity of obatoclax derivatives as novel and potent SHP-1 agonistsJung-Chen Su, Kuen-Feng Chen, Wei-Lin Chen, et al.Pageof 30